NCHR Comment on the USPSTF’s Draft Recommendations for Ovarian Cancer Screening

August 10, 2017. We strongly support the USPSTF’s draft recommendation to maintain the “D” grade for ovarian cancer screening, as well as their broader efforts to improve the health of all Americans by making evidence-based recommendations about clinical preventive services. As more high-quality research becomes available, we encourage the provision of additional recommendations about the benefits and harms of using new screening strategies in asymptomatic women who are not known to be at increased risk for ovarian cancer.

Read More »

Nonprofit Groups’ Letter to Commissioner Gottlieb on Menu Labeling

August 2, 2017. The FDA should maintain the current menu labeling requirements that allow Americans to easily access nutritional information about the food they purchase. Two thirds of adults and one third of children are overweight or obese and displaying nutrition information can help them make informed decisions.

Read More »

Patient, Consumer, and Public Health Coalition Letter to Senators Opposing the “Right to Try” Law

July 31, 2017. Sen. Johnson’s proposal would remove FDA from the process, allow companies to charge whatever they want, not allow FDA to consider any harm that the experimental drug causes when used under the Right To Try auspices, and thus eliminate the safeguards and monitoring that otherwise are done to determine whether the patient has been helped or harmed by the experimental drug.

Read More »

NCHR Response to Senate Health bill

July 28, 2017. All three versions of the so-called Better Care Reconciliation Act of 2017 would have resulted in much worse, not better, health care for Americans than our current healthcare program.

Read More »